Michigan has seen cases skyrocket 168% in five years, but the new vaccine candidate offers hope with strong trial results and ...
The vaccine could represent a weapon for preventing Lyme, a bacterial infection carried by ticks that is diagnosed and treated in an estimated 476,000 people in the US each year.
An announcement from Pfizer means Lyme disease numbers could soon drop.
Pharmaceutical giant Pfizer and French vaccine maker Valneva reported positive topline results from their phase three study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results